N.V. Lyubimova

Н.В. Любимова

10 articles 2010–2025

2025

Clinical and laboratory significance of GFAP and S100 content in blood serum of patients with various brain pathologies Technologies of Living Systems, No. 4, 2025 pp. 22-31

2022

Comparative analysis of serum levels of zonulin in healthy donors and patients with inflammatory bowel diseases Technologies of Living Systems, No. 3, 2022 pp. 15-21

2014

Tumor molecular markers in clinical oncology Technologies of Living Systems, No. 2, 2014 pp. 3-18
Biochemical markers of neuroendocrine tumors Вопросы биологической, медицинской и фармацевтической химии, No. 1, 2014 pp. 48-58

2013

Biochemical markers of small cell lung cancer Technologies of Living Systems, No. 2, 2013 pp. 34-49

2012

Free light chains - biochemical markers of monoclonal gammapathies Technologies of Living Systems, No. 9, 2012 pp. 15-20
C-terminale-telopeptide of type I collagen in urine of patients with breast cancer - prognostic factor of bone metastases Technologies of Living Systems, No. 3, 2012 pp. 3-7

2011

The Role of Factors of Angiogenesis in Patients with Neuroendocrine Tumors of Gastrointestinal Tract and Pancreass Вопросы биологической, медицинской и фармацевтической химии, No. 12, 2011 pp. 50-54
Biochemical Markers in Diagnostics and Treatment of Neuroendocrine Tumors (Review) Вопросы биологической, медицинской и фармацевтической химии, No. 12, 2011 pp. 28-37

2010

Carcinoid syndrome in neuroendocrine tumors of the organs of abdominal cavity and retroperitoneal space and it association with disease prognosis Вопросы биологической, медицинской и фармацевтической химии, No. 11, 2010 pp. 37-41